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Abstract 
Auditory verbal hallucinations depend on a broad neurobiological network ranging from the auditory system to 
language as well as memory-related processes. As part of this, the auditory N100 ERP component is attenuated in 
patients with schizophrenia, with stronger attenuation occurring during auditory verbal hallucinations. Changes in 
the N100 component assumingly reflect disturbed responsiveness of the auditory system towards external stimuli 
in schizophrenia. With this premise, we investigated the therapeutic utility of neurofeedback training to modulate 
the auditory-evoked N100 component in patients with schizophrenia and associated auditory verbal hallucinations. 
Ten patients completed electroencephalography neurofeedback training for modulation of N100 (treatment 
condition) or another unrelated component, P200 (control condition).  
On a behavioral level, only the control group showed a tendency for symptom improvement in the PANSS total 
score in a pre-/post comparison (t(4) = 2.71, p = 0.054), however, no significant differences were found in specific 
hallucination related symptoms (t(7) = -0.53, p = 0.62). There was no significant overall effect of neurofeedback 
training on ERP components in our paradigm; however, we were able to identify different learning patterns, and 
found a correlation between learning and improvement in AVH symptoms across training sessions (r = 0.664, n = 9, 
p = 0.05). This effect results, with cautious interpretation due to the small sample size, primarily from the treatment 
group (r = 0.97, n= 4, p=0.03). In particular, a within-session learning parameter showed utility for predicting 
symptom improvement with neurofeedback training.  
In conclusion, patients with schizophrenia and associated auditory verbal hallucinations who exhibit a learning 
pattern more characterized by within-session aptitude may benefit from electroencephalography neurofeedback. 
Furthermore, independent of the training group, a significant spatial pre-post difference was found in the event-
related component P200 (p = 0.04). 
Keywords 
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Introduction 
Auditory verbal hallucinations (AVH) are a common symptom of schizophrenia that is associated with significant 
psychological strain. These hallucinations can occur on a broad spectrum, with voices heard in varying volumes 
from one or several people with comprehensible or indistinguishable voices and friendly or hostile intents. AVHs 
can manifest occasionally or continuously in patients. Together, these features reflect substantial heterogeneity in 
AVHs across patients. 
Research in the last two decades indicates that AVHs arise from the abnormal and complex neurobiological 
interaction of language, auditory, and memory brain networks 1. Evidence specifically implicates the involvement 
of basic cortical areas such as the primary auditory cortex (PAC) 2, secondary auditory cortex, and premotor cortex; 
complex cortical structures including the prefrontal cortex and anterior cingulate cortex (ACC) 3; and subcortical 
and cerebellar regions (for an overview, see 4, 5). On this premise, it is not surprising that 25–30% of patients with 
schizophrenia are resistant to conventional treatment with antipsychotic medication 6. Alternative approaches such 
as psychotherapy 7 and non-invasive brain stimulation with transient direct current stimulation (tDCS) 8, 9 or 
repetitive transcranial magnetic stimulation (rTMS) 10, 11 have been implemented in patients with refractory 
schizophrenia with limited success. Accordingly, it has been hypothesized that there are heterogeneous biological 
subtypes of dysfunction that underlie phenotypes of AVH.  
Neurofeedback (NFB) is a therapeutic modality in which subjects learn to self-regulate brain activity through 
operant conditioning 12. NFB has been applied as an alternative therapeutic approach in several neuropsychiatric 
disorders including attention deficit hyperactivity disorder 13-16, epilepsy 17-19, and autism 20. In the context of 
schizophrenia, two early studies showed the feasibility of NFB for training the self-regulation of slow cortical 
potentials in patients 21, 22. The potential therapeutic use of NFB training for schizophrenia-associated AVHs was 
first proposed by McCarthy-Jones 23. To this end, two recent studies reported the ability of patients with 
schizophrenia to control activity in the ACC using real-time functional magnetic resonance imaging NFB 3, 24, the 
latter of which reported improvements in some aspects of AVH symptoms. Other more cost-effective tools for NFB 
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exist, including electroencephalography (EEG)-NFB; however, no study to date has explored EEG-NFB for the 
treatment of AVHs in patients with schizophrenia.  
Motivated by our own findings identifying the essential involvement of the PAC in AVH pathogenesis 2, 25, we 
examined the therapeutic utility of EEG-NFB for schizophrenia-associated AVHs using the N100 event-related 
potential (ERP) component as a training target. The N100 peaks between 80 and 120 ms after an auditory stimulus 
26, and its source has been localized in the PAC and secondary auditory cortex, ACC, and other parts of the temporal 
lobe and insula 27-29. The amplitude of N100 is generally attenuated in patients with schizophrenia 26, 30-32 and is 
further attenuated during hallucinations 25. Therefore, we hypothesized that decreases in the amplitude of N100 
might be an index of brain network dysfunction related to AVHs in patients with schizophrenia.  
A comparable background of the neurophysiology for AVH can be found in tinnitus patients. Those patients also 
showed a reduction of the ERP component N100 generated in the PAC, and were able to actively manipulate the 
amount of phase-locking onto an auditory stimulus by varying selective attention to competing auditory stimuli 33, 
34. Further, rtfMRI NFB of the PAC may reduce symptoms in patients with tinnitus 35.  
 On this premise, we tested the feasibility of N100 amplitude modulation training with EEG-NFB for improving AVH 
symptoms in schizophrenia. To control for non-specific effects, we included a second group that was trained to 
modulate another ERP component, P200, as a control condition. No alterations in the ERP P200 were reported in 
schizophrenia 31.  
Further, we investigated the effects of different learning parameters following a design previously implemented by  
Diaz and colleagues 36. Differentiating these learning parameters allowed us not only to analyze a time dependent 
change as function of being on task, classically labelled as “learning”, but also permitted the investigation of a time 
effect independent of being on task (labelled as “carry-over”) and an effect of being on task independent of time 
(labelled as “aptitude”). A carry-over effect visualizes the ability to passively learn to change a certain brain state. 
Aptitude quantifies the general ability of a subject to voluntary modulate a certain brain state and could act as a 
predictor for a positive therapeutic effect of EEG-NFB training on AVH symptoms.  
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Material and methods 
Subjects 
We screened a total of 170 inpatients and outpatients with schizophrenia who visited the University Hospital of 
Psychiatry in Bern over the two-year study recruiting period. Of these, twelve patients met the inclusion criteria 
and agreed to participate in our double-blind study. Two patients dropped out of the study after the 
psychopathological assessment, such that a total of ten patients (four women and six men; mean age, 36.6 ± 14.6 
years; age range, 19–61 years) were enrolled. One patient stopped after six, another after 14 sessions out of 16 
sessions. Both had been randomly assigned to the control group (P200). Eight patients were right-handed, one was 
left-handed, and one was ambidextrous according to the handedness questionnaire 37. Patients were between the 
ages of 18 and 65 years, able to participate in continuous NFB training over a two-week period, and had a verified 
diagnosis of schizophrenia (ICD-10: F20) or a schizoaffective disorder (ICD-10: F25). All patients were actively 
experiencing AVHs in their current phase of disease. Patients were excluded if they had another active psychiatric 
disease, neurological disease, problems with hearing or non-corrected vision, or were pregnant. 
Patients were randomly assigned to either the treatment group (N100 training) or the control group (P200 training) 
(Table 1) using a stratified randomization. All patients were fully informed about the nature and purpose of the 
study and provided written informed consent for participation. All procedures were approved by a local ethics 
committee (Kantonale Ethikkommission Bern, reference number: 193/13) and conducted in accordance with the 
most recent version of the Declaration of Helsinki.  
 
Design and questionnaires 
Figure 1 summarizes the experimental procedure. The experiment included two pre-sessions (1), eight NFB double 
sessions (2), and one post-session (3).  
Figure 1 about here 
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In the first pre-session (1), patients were fully informed about the experimental procedure and inclusion and 
exclusion criteria were evaluated. An interviewer collected demographic information and administered a set of 
questionnaires in a semi-structured interview format. Questionnaires included a) the Edinburgh Handedness 
Inventory 37 to assess handedness, b) the Positive and Negative Syndrome Scale (PANSS) 38 to assess psychotic 
symptoms, and c) the hallucination subscale of the Psychotic Rating Scale (PsyRats) 39 to assess different dimensions 
of AVH. Additionally, patients completed a short battery of cognitive tests including a) the Hopkins Verbal Learning 
Test-Revised (HVLT-R) of the MATRICS Consensus Cognitive Battery 40, 41 to assess verbal learning, b) the 
Neuropsychological Assessment Battery of the MATRIC Consensus Cognitive Battery (NAB-Mazes) 40, 41 to screen 
executive function, and c) the D2 Test of Attention 42 to assess selective and sustained attention. The second pre-
session (1) included a hearing test to confirm normal hearing ability (Diatec Screening Audiometer, AS 608) and a 
series of EEG recordings to construct filters used for later analyses (see EEG recording). 
For NFB training (2), patients completed eight double sessions over a two-week period with four training days per 
week. Each single-session lasted approximately 22 minutes, followed by a short break and a subsequent session of 
the same duration. After each single-session, patients verbally reported the strategies they used during training. 
After each double session, patients completed the Hallucination Change Scale (HCS) modified from Hoffmann et al. 
43 to assess overall changes in hallucination severity (independent of hallucination dimensions). HCS scores ranged 
from −10 (voices completely disappeared) to +10 (voices substantially increased). The first NFB session served as a 
baseline for subsequent sessions and thus was assigned a HCS score of 0 by default. 
The post-session (3) was conducted on a separate day after completion of the eight double sessions and included 
administration of a) the PANSS to assess symptom severity of positive and negative symptoms and b) the 
hallucination subscale of the PsyRats 39 to assess dimensions of AVH after the last training session. The NFB training 
was identical to our previous study in healthy controls 44 and is briefly summarized as follows: 
Patients were comfortably seated in a sound-shielded EEG cabin at a distance of 1.30 m from a computer monitor. 
All recordings were video-monitored to control for body movements.  For EEG recordings, an ActiCap system with 
32 channel-active electrodes (layout based on the 10–10 system with reference at FCz and ground at AFz) (Brain 
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Products GmbH, Germany) was used. Impedances were maintained below 20 kΩ. Signal were amplified (BrainAmp 
32-channel amplifier, BrainProducts GmbH) band pass-filtered (0.3–70 Hz) and sampled at 500 Hz.  
ERP feature extraction 
In accordance with Hubl et al. 25, a simple series of 1000-Hz sinusoidal tones with a duration of 70 ms (rise 10 ms, 
plateau 50 ms, fall 10 ms) was used to evoke the target ERP component (N100 or P200). Beep tones were presented 
with an inter-stimulus interval of 1430 ± 140 ms and delivered by a standard hi-fi audio amplifier (Technics V300 
Mark 2, Panasonic, Japan) . 
Pre-session recording 
Figure 2 shows a schematic of the recording and analysis procedure. In the pre-session, 3 EEGs were recorded: First 
a) an 8-min resting-state EEG with eyes-open/eyes-closed (alternating every 2 min), followed by b) recording of 
voluntary eye movements (blinking, left-right movement, and up-down movement) to allow the offline 
construction of c) a spatial filter by means of an independent component analysis for later online removal of ocular 
movements, and (3) a 4-min recording during exposure to the beep tones later used in NFB training (Figure 2, item 
d). 
Figure 2 about here 
Individual temporal and spatial filters (Figure 2, items e-f) were constructed from the pre-session EEG data with the 
stimulation to extract ERP amplitudes on a single-trial level as follows: first, the EEG data recorded during 
stimulation was band pass-filtered from 1–30 Hz, recomputed to the average reference, and segmented from 0–
500 ms post-stimulus and baseline-corrected. A wavelet transformation using real Gabor-functions was performed 
on single-trial ERPs. To obtain the most sensitive frequency filter and latency, 1-sample t-tests were computed 
across trials for all electrodes, time points, and wavelet layers. The absolute values of these t-values were averaged 
across channels and used as a global index of the overall signal-to-noise ratio across time, frequency and space. For 
the detection of single-trial N100 and P200 amplitudes, the optimal individual latency and frequency layer were 
identified at the peak of these average t-values in the corresponding time range. Spatial filters were computed as 
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average maps across trials at the optimal frequency and latency (Figure 2, item g). Single-trial N100 and P200 
amplitudes were thus defined as the weighted sum of all electrodes of the wavelet-filtered EEG at the individually 
defined latency, where the weights were defined by the spatial filter. 
Online analysis of NFB training 
Online single-trial extraction of the N100 amplitude was performed using build-in and in-house developed plug-ins 
for RecView (Brain Products GmbH). The raw data was filtered online with the previously constructed spatial filter 
for ocular movements and recomputed to the average reference. Then, a spatial filter and a temporal wavelet filter, 
defined based on the individual optimal frequency and latency, were applied to the resultant EEG data to extract 
the N100 ERP component on a single-trial level (Figure 2, item h). Visual feedback was provided during NFB training 
based on this information (Figure 2, item i). 
Visualization of the feedback was provided using PsychoPy 45, depicted a balloon rising in accordance with the N100 
amplitude. The following rule was used to update the position of the balloon: 
𝑦𝑦𝑡𝑡 = 𝑦𝑦𝑡𝑡−1 + (𝑠𝑠 − 𝑦𝑦𝑡𝑡−1) ∗ 𝑘𝑘 
where 𝑦𝑦𝑡𝑡 is the value fed back to the subject at trial t, s is the value of the single-trial quantifier of the N100 
amplitude at trial t, and k is a constant (0.2 in the current experiment).  
NFB training protocol 
Each NFB training session consisted of 3 different conditions: a passive condition and 2 active conditions (training 
and transfer). Each session included 8 2.5-min blocks with the following structure: passive condition, 4 training 
blocks, passive condition, transfer block, passive condition. During all blocks, beep tones were used to evoke the 
target components. For the first passive condition block, patients were instructed as follows: “Try to relax and listen 
to the beep tone while focusing the screen without thinking about anything in particular.” The visual feedback 
symbol was a static frame (i.e., no feedback). Based on the values of the target component amplitude in the first 
passive condition block, a threshold was set that predicted a positive feedback 60% of the time. Patients assigned 
to the treatment group received feedback on the N100 component, whereas patients assigned to the control group 
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received feedback on the P200 component. The consecutive 4 training blocks were accompanied by the following 
instruction: “Try to make the balloon fly as high as possible.” Patients were instructed to use mental strategies to 
regulate the height of the balloon. These strategies could be changed during the blocks and/or across repetitions. 
The last condition (“transfer”) was between 2 passive conditions; during this condition, patients did not receive any 
feedback while fixating the screen (i.e., there was no balloon displayed on the screen). The instruction was as 
follows: “Try to reproduce the same state as in the training blocks where the balloon was flying high by using the 
same mental strategies.” After each block, patients were allowed to take an individually defined short break before 
pressing a button to continue on to the next block.  
Statistical analysis 
Table 2 depicts an overview of the main analysis that were performed. The main goal of the analyses was to quantify 
systematic improvements of the clinical symptoms through NFB training, and NFB related changes of the ERP 
components. In addition, we were interested in knowing if there were systematic relationships between the NFB 
learning patterns, pre-training psychopathology, and changes in hallucinations. Given the complexity of the data, 
these analyses included a part that reduced the dimensionality of the psychopathology and neurophysiology data 
using principal component analyses (Table 3), followed by correlational analyses linking these reduced set of 
features. All analyses used a threshold of p < 0.05 for statistical significance. All statistical analyses were performed 
using the Statistical Package for the Social Sciences version 24 (SPSS, IBM). Linear mixed models were estimated in 
R 46. 
Demographics, pre-and post-training group differences in clinical scores 
To test whether the NFB training had a systematic effect on schizophrenia psychopathology (Table 2, I), PANSS total 
score and PsyRats scores of the hallucination subscale were compared for each group between pre- and post-
session using paired t-tests and Wilcoxon rank-sum tests, respectively. 
Table 2 about here 
Pre- post differences in hallucinations 
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The primary outcome variables of our study were changes in clinical features after the training compared to the 
pre-training (Table 2, II). Thus, the HCS of the second-to-last session was subtracted from that of the first session 
to yield an HCS difference score; a positive difference score indicated a decrease in hallucinations. Data from the 
second-to-last session was used due to the dropout of a subject in the last session. To test whether NFB training 
had a systematic effect on AVH severity, the HCS difference score was compared to 0 across all subjects. Similarly, 
differences in the pre-post changes in PANSS total score and PsyRats scores of the hallucination subscale were 
computed and tested against zero using one-sample t-tests. 
Group effects in pre- post differences in hallucinations 
To test whether the training type (N100 vs P200 feedback) systematically affected the changes in hallucinations, 
the HCS pre-post difference score were compared between training groups using an independent-samples t-test 
(Table 2, III). Similar tests were computed for group differences in pre-post changes in PANSS total score and PsyRats 
scores of the hallucination subscale. 
Parametrization of individual NFB training patterns 
For the parameterization of the NFB training pattern (Table 2, IV), the neurophysiological data was individually 
modeled across and within sessions. A description of the different learning parameters across and within sessions 
is shown in table 3, and briefly reiewed here: For across- and within-session analyses, we distinguished three 
different learning parameters in accordance with the methods of Diaz Hernandez et al. 36: First, a basic ability to 
increase the AEP component as a function of task, henceforth referred to as “aptitude” (training aptitude and 
transfer aptitude), second voluntary learning, i.e. a time dependent change occurring selectively during the task, 
and third involuntary learning, i.e. a task independent change across time. Thus, voluntary learning describes an 
increase over time in the component amplitude in one of the active conditions (training or transfer) compared to 
the passive condition as a baseline, and is henceforth referred to as either “training learning” or “transfer learning.” 
Involuntary learning describes amplitude increases over time in the passive condition either within or across 
sessions and is henceforth referred to as “carry-over.” To assess these different learning parameters in each subject, 
we used a linear regression model that included a random factor defined as time (i.e., session for the across-session 
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analysis and repetition for the within-session analysis), a random factor defined as condition (passive or active: 
training or transfer), and a random interaction factor of time and condition, following a design that had been 
previously implemented by Rieger and colleagues 44. The use of a linear mixed effect model allowed handling 
incomplete data sets. Therefore, all data sets with at least six sessions were included in the analyses of the 
neurophysiological data. The obtained β-values were tested for significance across subjects using t-statistics. To 
reduce the number of tests in the further analyses, the set of individual learning parameters for the within and 
across session effects were submitted to a principal component analysis (PCA). From this PCA, individual scores of 
the first component were extracted and used as reduced quantifiers of NFB training patterns (later referred to as 
learning factor). 
Group comparisons of NFB training patterns 
In order to compare the two patient groups, the linear mixed models described above included group as a 
categorical predictor. This allowed us to test for group specific differences in the above outline NFB training patterns 
(Table 2, V). 
Table 3 about here 
Relationship of hallucination changes and NFB learning type 
It is quite possible that individual NFB learning patterns have an effect on the clinical outcome of the training. To 
test this hypothesis, we correlated the individual pre- post differences in hallucinations with the individual factor 
score summarizing the NFB learning pattern (the learning factor) using a Pearson correlation coefficient (Table 2, 
VI). 
Extraction of psychopathological characteristics 
The individual psychopathology may be an important, but high-dimensional moderator in our analyses. To reduce 
problems of multiple testing, we therefore reduced the dimensionality of the psychopathology data, again using a 
PCA, and including the data of the individual sub-scores of the PsyRats, PANSS positive and negative scores, the 
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Calgary Depression Scale Schizophrenia (CDSS) 47 and the wellbeing sub-score of the CORE 48. From this PCA, 
individual scores of the first component were extracted and used as reduced quantifiers of individual 
psychopathology (Table 2, VII; Table 3). 
Relationship of pre-training psychopathology and NFB learning type 
To test whether the pre-training psychopathology was predictive for NFB learning success, we correlated the 
individual factor scores for the pre-training psychopathology with the individual factor scores obtained for the NFB 
training patterns, i.e. with the learning factor (Table 2, VIII). 
Pre-post differences in ERP topography and source estimates 
Finally, to assess whether NFB training caused changes in ERP topography and source estimates, averaged ERPs 
during the first block of passive listening were compared between first and last training sessions (Table 2, IX). To 
localize brain regions affected by the training, source estimates of the ERPs were computed as follows: ERPs were 
band pass-filtered from 1.5–15 Hz, recomputed to the average reference, and corrected for eye-movement artifacts 
with an independent component analysis. The time windows of the N100 and P200 components were defined using 
a microstate analysis 49 that parsed data into periods of quasi-stable field configurations, thereby collapsing data 
across time periods with presumably stable source configuration. Within the N100 and P200 microstates, we 
compared the amplitude-normalized spatial configurations of the ERP fields using topographical analyses of 
variance (TANOVAs) 50 and the mean global field power (GFP), which quantifies the overall potential variance across 
electrodes 51 between pre- and post-training. Significant TANOVA results were further analyzed by statistical 
mapping of sLORETA voxel-wise inverse solutions to estimate the sources accounting for training effects. sLORETA 
inverse solutions were computed using sLORETA software 52 using a boundary elements head model derived from 
the MNI 152 template with a total of 6239 voxels (voxel size, 5 × 5 × 5 mm3) covering the gray matter of the brain. 
The regularization parameter SNR was set to 100. Paired t-statistics across subjects were used to assess significant 
local differences. Given that the overall null hypothesis was rejected by the previous TANOVA in this situation, no 
further corrections for multiple comparisons were applied. The obtained t-values were thresholded by a t-value 
corresponding to a two-tailed significance level of 1% 53.  
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Results 
Demographics, pre-and post-training group differences in clinical scores 
Of the ten patients enrolled in NFB training, one patient dropped out after six NFB sessions and another patient 
dropped out after 14 sessions (out of a total of 16 sessions). Table 1 summarizes the clinical findings. There were 
no significant between-group or within-group differences in the pre-post comparison of psychopathological 
symptoms (Table 2, I).  
The P200 control group showed a tendency for symptom improvement with regard to PANSS score (pre-test vs. 
post-test, t(4) = 2.71, p = 0.054). None of the cognitive test scores (HVLT-R, NAB-Mazes, or D2 test of attention) were 
significantly associated with any learning parameter. 
Table 1 
Pre- post differences in hallucinations 
There were no consistent changes in the HCS on an overall level (Table 2, II): Independent of group, three subjects 
showed improvement, three showed no change, and three showed deterioration (Figure 3). 
Figure 3 
Group effects in pre- post differences in hallucinations 
As shown in Figure 3, there were no significant differences in AVH symptom improvement (HCS difference score) 
between the treatment and control group (t(7) = −0.53, p = 0.62) (Table 2, III).  
Parametrization of individual NFB training patterns 
Similarly to the already published analysis of the results obtained when the same training protocol was applied to 
healthy subjects (but not yet known when we conducted the training of the patients), a linear mixed model 
including a regressor for the first vs second session per day (Table 2, IV) indicated that training was ineffective in 
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patients in the second session (β = -0.08, t = -1.89, p = 0.06). As in the paper on the healthy subjects, the data from 
the second session per day was therefore not included in the remaining analyses. 
The individual parameters of the linear mixed model explaining the NFB learning behavior, as well as the statistics 
on the β-values are shown in Figure 4. A significant negative effect of carry-over was identified. Decreases in 
amplitude of the trained ERP component were interpreted to be the result of a habituation effect 54, 55. Patients 
showed a trend of within-session training learning; however, this effect was non-significant. 
The loading of the different NFB learning parameter on the extracted principal factor is shown in Table 3. Closer 
inspection of the load structure indicates that in our data, subjects primarily varied along a dimension showing, in 
parallel, more within-session training aptitude, within-session carry-over (amplitude increases in the passive 
condition) as well as across-session learning (amplitude increases in training relative to baseline), or the reverse. 
We will therefore refer to positive values of this load as sustained learning, whereas negative values will be referred 
to as transient learning. 
Group comparisons of NFB training patterns 
There were no significant effects of group on EEG-NFB performance across sessions (Group effect: t = -1.22, p = 
0.25; Aptitude x Group effect: t = -0.29, p = 0.78; Day x Group effect: t = 0.37, p = 0.72; Learning x Group: t = -0.00, 
p = 0.99) or within sessions (Group effect: t = -0.63, p = 0.54; Aptitude x Group effect: t = -1.12, p = 0.26; Repetition 
x Group effect: t = -0.83, p = 0.41; Learning x Group effect: t = 0.95, p = 0.35). Based on this result, subsequent 
neurophysiological analyses were performed across all patients (i.e., independent of group) (Table 2, V). 
Relationship of hallucination changes and NFB learning type 
To test for a systematic relationship between NFB learning and AVH severity (Table 2, VI), we used the Pearson 
product-moment correlation value between the individual scores of the NFB learning factor and the HCS difference 
score across both groups (treatment and control). Results showed a significant effect (r = 0.66, n = 9, p = 0.05, Figure 
5). Patients showing more of the sustained NFB learning pattern showed an improvement in the hallucinations 
compared to those patients that showed more of the transient learning pattern.  
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Breaking this further down, a separate correlation analysis for each group yielded a strong significant correlation 
between the learning factor and the change in hallucinations in the treatment group (r = 0.97, n = 4, p = 0.03), 
whereas no significant correlation was found in the control group (p = 0.23, n = 5, p = 0.72). However, a cautious 
interpretation is necessary due to the small group numbers. These results showed that a positive load in the 
learning factor was positively associated with an improvement in the hallucinations.  
Figure 5 about here 
Extraction of psychopathological characteristics 
The analysis of the relationship of NFB learning and psychopathology was based on a factor analysis of the various 
psychopathology scores. The loading of these different scores on this psychopathology factor is shown in Table 3. 
The factor was primarily indicative of a negative content of AVH, a high amount of distress and absence of wellbeing, 
or the reverse (Table 2, VII). 
Relationship of pre-training psychopathology and NFB learning type 
To test whether pre-training symptom severity could predict NFB learning, factor scores obtained from clinical data 
were correlated with the scores of the NFB learning factor. Pearson product-moment correlation coefficients were 
non-significant (r = 0.01, n = 10, p = 0.98) (Table 2, VIII). 
Pre-post differences in ERP topography and source estimates  
A microstate analysis identified the exact time interval of the N100 component as 79–119 ms with typical central 
negativity, and that of the P200 component as 136–204 ms (Table 2, IX). For the N100, there was no significant 
spatial difference (p = 0.28) or GFP effect (p = 0.14) identified in the pre-post comparison. For the P200, there was 
a significant spatial pre-post difference (p = 0.04) and a tendency for higher GFP during post-training (p = 0.07). In 
the P200 interval, voxel-wise paired t-tests of sLORETA estimates were significant in the right PAC (Brodmann area 
[BA] 41 and 42); superior temporal gyrus (BA 22); inferior temporal gyrus, fusiform gyrus, and parahippocampal 
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gyrus (BA 20); posterior cingulate cortex (BA 29 and 30); parahippocampal gyrus (BA 35 and 36); and insular cortex 
(BA 13) (Figure 6).  
Investigating group specific influences of the N100 training (treatment group) on the P200 component showed a 
significant topographical (p = 0.002) and GFP effect (p = 0.002) in the pre-post comparison, but not within the N100 
component. However, P200 training (control group) did not significantly affect the N100 nor the P200 components 
in these analyses. 
Figure 6 about here 
Discussion 
The goal of this study was to evaluate the utility of N100 EEG-NFB training for treating AVH symptoms in patients 
with treatment-resistant schizophrenia. Contrary to our hypothesis, NFB training did not afford significant 
improvements in schizophrenia psychopathology. The P200 control group showed a tendency for a reduction in the 
total score of the Positive and Negative Syndrome Scale (PANSS) after the last NFB training session compared to 
the first session. A possible explanation could be an effect of treatment expectation. This, however, does not explain 
an increase in the total PANSS score seen in the treatment group. Considering this, the tendency for a reduction in 
the total score of the PANSS in the control group might result from the fact that this group started with a higher 
score compared to the treatment group in the first place, and thus may be explained as a regression to the mean. 
Comparing the total score after the training in both group showed that, despite a tendency for a reduction, the 
control group still showed a higher score compared to the treatment group. 
We did not identify relationships between individual psychopathological characteristics and NFB performance, 
indicating that symptom severity was not a predictor for NFB learning. This is in line with Gruzelier et al. 21 who 
concluded that the psychotic symptoms of schizophrenia are not as obstructive for learning as other factors such 
as anxiety or loss of motivation in NFB tasks. Our result is consistent with this observation.  
The use of a mixed effects model analysis allowed us to model NFB data with different learning parameters. With 
regard to NFB performance, Gruzelier et al 21 previously described the differentiation of within-session and across-
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session learning. Diaz Hernandez et al. 36 further distinguished between training aptitude and training learning 
within and across sessions. Assessing a learning factor based on the different learning parameters showed a 
dimensional distribution of NFB performance in the patients with opposing characteristics: More sustained learning 
was associated with more within-session aptitude and across-session learning, with less within-session learning and 
across-session aptitude and carry-over. More transient learning was related to an opposite pattern, exhibiting 
better within-session learning and across-session carry-over and aptitude. To further explore the significance of 
these learning parameters, we examined the relationship between these learning dynamics and AVH severity. As 
described above, comparing group averages in the psychopathology did not show a significant effect. A more 
accurate representation of psychopathological symptoms might however be seen in a dimensional approach 56. 
Following this assumption, correlation measures were used to assess the relationship between NFB learning and 
AVH. There was a significant correlation between learning and change in hallucination severity in pre- and 
posttraining comparison, indicating that subjects rather showing sustained learning experienced a decrease in the 
perception of AVHs post-training. Within sustained learning, training aptitude was negatively associated with AVH 
severity. Training aptitude represented the general ability of a subject to increase the trained ERP in the training 
condition compared to the passive condition, independent of time (number of sessions). Therefore, within-session 
aptitude is not a measure of rapid learning, but is rather a quality that was inherent or developed slowly across 
repeated sessions. It is possible that subjects showing more sustained learning had a pre-existing advantage (within-
session aptitude) that allowed them to improve their control of AVHs. Hence, within session aptitude may be an 
important predictor of NFB-training performance and therapeutic benefit. In summary of these findings, the target 
component of EEG-NFB (i.e., N100 or P200) did not appear to have any significance for the effect of NFB on AVH 
symptoms or control; rather, within-session aptitude was more relevant to therapeutic success. This observation 
can be explained by the hypothesis that a common mechanism was affected by the training of both components. 
Finally, it is noteworthy that we identified a significant spatial difference in the source of P200 in our pre-
training versus post-training comparison, mainly in temporal regions (i.e., the PAC and superior and inferior 
temporal gyri) and parts of the limbic system (i.e., posterior cingulate cortex and parahippocampal gyrus). The role 
of P200 is not yet fully understood 57, 58; however, attention seems to influence its amplitude. Crowley and Colrain 
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57 reported that a higher attention load led to a decrease in P200 amplitude. Tremblay et al. 59 observed increases 
in P200 amplitude after auditory evoked potential exposure and concluded that this effect arose from task exposure 
or execution. Since we identified a spatial P200 effect that was independent of group (treatment or control) and 
NFB performance, it is assumed that P200 does not represent  a biomarker for learning 59.  
The present study had some limitations. First, despite a modification of the P200 amplitude across training sessions, 
our data did not support an effect of EEG-NFB training on the N100 amplitude using our protocol. This may have 
been due to the fact that we tried to modify a component that was already disturbed in patients with schizophrenia. 
Alternatively, it is possible that we did not use a protocol that sufficiently enforced modification of the N100 
amplitude (e.g. using a different beep tone interval, or omitting the need for strategy development). 
Second, another limitation is given by the number of sessions needed in a clinical disorder. It has been previously 
shown that schizophrenia patients needed more training sessions than healthy subjects in order to achieve the 
same control in neurofeedback22. In addition, our data suggested that the second session of each day was not 
helpful for the training. Therefore, we suggest that future studies consider distributed learning across more training 
sessions for patient groups and at the same time avoiding too long training sessions or double sessions that outstrip 
the patients’ capacity to concentrate and properly train with NFB.  
Third, and relevant to our first limitation, we were only able to recruit a small number of participants despite a 
substantial two-year effort. Thus, a lack of statistical power may have driven our inability to identify effects of EEG-
NFB and between-group differences. Taken together, we were unable to conclude whether targeting the N100 
amplitude is a useful feature of EEG-NFB training. However, significant effects in the treatment group (N100 
training) on the ERP P200 component indicated a change through the N100 NFB training, which was not found in 
the control group (P200 training). At the same time, these results do not interfere with the primary goal of affecting 
auditory verbal hallucinations through modulation of the N100. Nonetheless, the interpretation of this finding 
remains open and needs further investigation.  
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Future studies should adopt a NFB protocol that better targets the N100 amplitude, or alternatively consider the 
use of another method such as TMS or tDCS to modulate N100 amplitude. Moreover, further studies should explore 
the mechanism by which subjects with sustained learning experienced improvements in AVHs in our paradigm.  
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Tables: 
 
 
Table 1: Demographic and psychopathological data
M SD M SD coeff p-value
age (years) 37,2 18,2 36,2 13,5 t = -0.11 p = 0.92
education (years) 10,3 1,5 11,7 2,1 t = 1.17 p = 0.28
medication (CE) 333,3 245,0 616,5 389,1 t = 1.28 p = 0.24
PsyRats pre 29,5 9,3 32,0 6,9 t = 0.47 p = 0.66
PsyRats post 29,0 7,4 31,8 6,4 U = 9.0 p = 0.61
PANSS pre 49,5 8,1 65,0 13,4 t = 1.75 p = 0.12
PANSS post 56,3 13,2 58,8 13,7 t = 0.28 p = 0.78
coeff p-value coeff p-value
PsyRats: pre - post Z = 0.0 p = 1.0 Z = -0.55 p = 0.58
PANSS: pre - post t = -2 p = 0.14 t = 2.71 p = 0.054
Statistics
Demographics
Psychopathology
Treatment (N100) Control (P200)
n = 4 n = 6
CE = Chlorpromazine equivalents [mg], M = mean; SD = standard deviation; coeff = coefficient; PsyRats = Psychotic 
Rating Scale; PANSS = Positive And Negative Syndrome Scale
Treatment vs. Control 
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Table 2: Overview of the performed analyses 
  
Pre-and post 
training state Pre-post difference 
IV: Individual NFB training patterns 
(parametrization using linear mixed models 
and PCA) 
  Group-wise Group-wise Overall Group-wise Overall 
        
V: Group 
comparisons of NFB 
training patterns 
(linear mixed models)   
Demographics and 
clinical scores 
I: Demographics, pre-
and post-training 
group differences in 
clinical scores (t-tests 
/ U-tests)         
Change in 
hallucinations 
(assessed by the 
HCS)   
III: Group effects in 
pre- post differences 
in hallucinations (t-
tests) 
II: Pre- post 
differences in 
hallucinations (t-tests) 
  
VI: Relationship of 
hallucination changes 
and NFB learning 
type 
VII: Extraction of 
psychopathological 
characteristics 
(PCA)         
VIII: Relationship of 
pre-training 
psychopathology and 
NFB learning type 
Evoked potentials 
    
IX: Pre-post 
differences in ERP 
topography and 
source estimates.     
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Figures: 
Figure 1. Overview of the experimental procedure 
Figure 2: Schematic overview of the pre-session and NFB training, Abbreviations: AEP, auditory evoked potential. 
Figure 3. Hallucination Change Scale scores at the first training session (HCS pre) and thirteenth training session 
(HCS post) 
Figure 4. Overview of individual subject performance for each learning parameter within and across sessions 
Figure 5. Correlation between NFB learning and change in hallucinations 
Figure 6. Significant pre-training versus post-training spatial differences (p < 0.01) in the P200 component 
